VIK insider files Rule 144 to sell 54,648 ordinary shares

An affiliate of VIK has filed a Rule 144 notice to sell 54,648 ordinary shares through Morgan Stanley Smith Barney LLC on the NYSE.

Rhea-AI Filing Summary

An affiliate of VIK has filed a Rule 144 notice to sell 54,648 ordinary shares through Morgan Stanley Smith Barney LLC on the NYSE. The shares to be sold have an aggregate market value of $3,674,389.44, based on the price used in the notice. The filing notes that 314,950,576 ordinary shares were outstanding at the time referenced, which is a baseline figure for the issuer’s total equity.

The securities originated from restricted stock vesting under a registered plan on 12/01/2025, with two blocks of 18,957 and 35,691 shares acquired from the issuer and paid for in cash on the same date. The person on whose behalf the sale is to be made represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

What does the Form 144 filing for VIK disclose?

The Form 144 notice discloses a proposed sale of 54,648 ordinary shares of VIK on the NYSE, with an aggregate market value of $3,674,389.44, to be executed through Morgan Stanley Smith Barney LLC.

How many VIK shares are planned to be sold under this Rule 144 notice?

The filing covers a proposed sale of 54,648 ordinary shares of VIK, as listed in the securities information table.

What is the origin of the VIK shares being sold on this Form 144?

The shares come from restricted stock vesting under a registered plan on 12/01/2025. Two vesting tranches are listed: 18,957 shares and 35,691 shares, both acquired from the issuer and paid for in cash on that date.

What total number of VIK shares were outstanding at the time referenced in the filing?

The notice states that 314,950,576 ordinary shares of VIK were outstanding at the time referenced, providing context for the issuer’s total equity base.

When is the approximate date of the VIK share sale under this Form 144?

The approximate date of sale listed in the Form 144 is 12/01/2025.

Which broker is handling the proposed VIK Rule 144 sale and on which exchange?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE.

What representation does the selling person make in this VIK Form 144?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/01/2025 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002029965
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VIKING HOLDINGS, LTD.
SEC File Number	001-42039
Address of Issuer	5700 Canoga Avenue Woodland Hills CALIFORNIA 91367
Phone	(818) 227-1234
Name of Person for Whose Account the Securities are To Be Sold	LINH BANH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	54648	3674389.44	314950576	12/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	12/01/2025	Restricted stock vesting under a registered plan	Issuer			18957	12/01/2025	Cash
Ordinary Shares	12/01/2025	Restricted stock vesting under a registered plan	Issuer			35691	12/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	These ordinary shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of ordinary shares upon the vesting and settlement of certain restricted share units.
Date of Notice	12/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Linh Banh
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)